Related Experiment Videos
Erythrocyte creatine levels in hyperthyroidism
M Arumanayagam1, C S Feng, C S Cockram
1Department of Chemical Pathology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories.
Pathology
|July 1, 1994
Summary
Hyperthyroidism lowers red blood cell size (MCV), but this study found no evidence of premature red blood cell aging. Erythrocyte creatine levels were similar in hyperthyroid patients and controls, ruling out senescence as the cause.
Area of Science:
- Endocrinology
- Hematology
- Cell Biology
Background:
- Hyperthyroidism is associated with a decrease in erythrocyte mean corpuscular volume (MCV).
- The underlying mechanism for this reduction in MCV remains unclear.
- Erythrocyte senescence is a potential, yet unproven, contributor to decreased MCV in hyperthyroidism.
Purpose of the Study:
- To investigate whether premature erythrocyte senescence contributes to the reduced MCV observed in hyperthyroid patients.
- To evaluate erythrocyte creatine levels as a marker of senescence in hyperthyroidism.
Main Methods:
- Erythrocyte creatine levels were measured in patients with hyperthyroidism and compared to healthy control subjects.
- Erythrocyte creatine was used as a biomarker to assess the rate of red blood cell aging.
Main Results:
- Erythrocyte creatine levels did not differ significantly between hyperthyroid patients and control subjects.
- This indicates that the red blood cells in hyperthyroid individuals are not prematurely aging.
Conclusions:
- Premature senescence of erythrocytes does not appear to be the mechanism responsible for the decreased MCV in hyperthyroidism.
- Further research is needed to elucidate the exact cause of reduced MCV in hyperthyroid conditions.